Stay updated on Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe latest history entry shows Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded a new Study Status entry (version 108) on 2026-04-08, updating the record with the trial's current status.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the history.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No other content or functionality on the page was affected.SummaryDifference0.0%

- Check73 days agoChange DetectedThe history now includes a new entry: Revision: v3.4.2; the previously visible notice about government funding delays and the prior Revision: v3.4.1 have been removed.SummaryDifference0.3%

- Check81 days agoChange DetectedAdded a government funding lapse notice at the top directing users to cc.nih.gov and opm.gov; updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.